Make it yours

At SYG BIOTECH, we are dedicated to pushing the limits of science to improve patient health and well-being around the world. We provide tailor-made solutions to our partners including biopharmaceutical enterprises, research organizations, and service providers that engage in drug development and clinical research. Our screening platform allows for the rapid identification of small molecule ligands that can effectively bind to target proteins, potentially serving as therapeutic agents. Join us as we set new standards in biotechnology and unlock the potential of personalized medicine.

Nanobodies (VHH) screening

A high-throughput screening platform for screening and identifying Nanobodies (VHH) that can bind to target proteins.

DARPins screening

a high-throughput in vitro screening platform for identifying Designed Ankyrin Repeat Proteins that can bind to target proteins.

Protein-protein Interaction bioassay

Drug-ligand interaction assays are essential in drug discovery and development processes. These assays enable scientists to study the interactions between potential drug compounds and target ligands, such as proteins